Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer
- PMID: 1977515
Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer
Abstract
Allele loss on a specific chromosome has implied the existence of a tumor suppressor gene such as the p53 gene and the RB gene. In order to determine which chromosome(s) carries a tumor suppressor gene(s) that contributes to tumor progression in primary breast cancer, we analyzed the loss of heterozygosity for each autosomal chromosome arm by using 39 restriction fragment length polymorphism markers including 25 variable numbers of tandem repeat probes. In 79 primary breast cancers, we found the frequent loss on the long arm of chromosome 13 (21%), the long arm of chromosome 16 (45%), and the short arm of chromosome 17 (56%). Interestingly, breast cancers in which loss of both chromosomes 13q and 17p was detected showed more malignant histopathological features, and a group of the tumors in which chromosome 16q loss was detected presented with frequent lymph node metastasis. Furthermore, the result of the deletion mapping on chromosome 17p implied the existence of a tumor suppressor gene distal to the p53 gene as well as the p53 gene itself for primary breast cancer. These results suggest that at least 4 tumor suppressor genes exist on chromosomes 13q, 16q, and 17p for primary breast cancer.
Similar articles
-
Accumulation of genetic alterations and progression of primary breast cancer.Cancer Res. 1991 Nov 1;51(21):5794-9. Cancer Res. 1991. PMID: 1682035
-
Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.Clin Cancer Res. 1995 Mar;1(3):261-7. Clin Cancer Res. 1995. PMID: 9815981
-
Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.Cancer Res. 1992 Jul 15;52(14):3914-7. Cancer Res. 1992. PMID: 1617666
-
[Molecular analysis of breast cancers: recent developments].Bull Cancer. 1992;79(12):1115-33. Bull Cancer. 1992. PMID: 1304832 Review. French.
-
[Cytogenetic abnormalities, genetic alterations, and applications for genetic diagnosis in breast cancer].Nihon Rinsho. 1996 Dec;54(12):3389-97. Nihon Rinsho. 1996. PMID: 8976125 Review. Japanese.
Cited by
-
MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.Med Sci Monit. 2012 Aug;18(8):BR299-308. doi: 10.12659/msm.883262. Med Sci Monit. 2012. PMID: 22847191 Free PMC article.
-
Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth.J Neurooncol. 2004 Dec;70(3):301-7. doi: 10.1007/s11060-004-9165-3. J Neurooncol. 2004. PMID: 15662971
-
Identification of high-risk breast cancer patients from genetic changes of their tumors.Surg Today. 2000;30(6):516-22. doi: 10.1007/s005950070118. Surg Today. 2000. PMID: 10883462
-
E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma.Urol Res. 1993;21(5):359-62. doi: 10.1007/BF00296837. Urol Res. 1993. PMID: 7506464
-
Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5950-4. doi: 10.1073/pnas.92.13.5950. Proc Natl Acad Sci U S A. 1995. PMID: 7597059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous